Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Product Type
Item No. 35650

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
α-Helical CRF (9-41) is a synthetic peptide antagonist of corticotropin-releasing factor (CRF).1 It inhibits CRF-induced adrenocorticotropic hormone (ACTH) release from isolated rat anterior pituitary cells when used at concentrations ranging from 0.5 to 5 µM. In vivo, α-helical CRF (9-41) (0.02-0.6 µmol/kg) inhibits CRF-induced ACTH release in non-anesthetized, intact rats. It also inhibits stress-induced ACTH release in rats when administered at a dose of 0.6 µmol/kg. α-Helical CRF (9-41) increases social interaction time in a rat model of nicotine-induced conditioned anxiety.2 It also reduces binge-like ethanol consumption in mice.3
WARNING This product is not for human or veterinary use.
1. Synthetic competitive antagonists of corticotropin-
2. Corticotropin releasing factor antagonist, alpha-
3. CRF-